title: Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group.
authors.forename: P
authors.initials: P
authors.lastname: Garred
authors.forename: J
authors.initials: J
authors.lastname: Eugen-Olsen
authors.forename: A K
authors.initials: AK
authors.lastname: Iversen
authors.forename: T L
authors.initials: TL
authors.lastname: Benfield
authors.forename: A
authors.initials: A
authors.lastname: Svejgaard
authors.forename: B
authors.initials: B
authors.lastname: Hofmann
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000235:genetics* / Q000276:immunology / Q000401:mortality; D000483:Alleles; D018791:CD4 Lymphocyte Count; D005500:Follow-Up Studies; D017353:Gene Deletion; D006679:HIV Seropositivity / Q000235:genetics* / Q000276:immunology / Q000401:mortality; D015497:HIV-1 / Q000235:genetics*; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D008297:Male; D019713:Receptors, CCR5; D018121:Receptors, Cytokine / Q000235:genetics*; D015728:Receptors, HIV / Q000235:genetics*; D015996:Survival Rate
chemical_list: D019713:Receptors, CCR5; D018121:Receptors, Cytokine; D015728:Receptors, HIV